Art clinical trials

Explore recruiting art clinical trials.

Recruiting art studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Art trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Inhibiting the anti-apoptotic factor, BCL-2, at the time of ART initiation to promote apoptosis of HIV-infected cells and restrict the seeding of the HIV reservoir: An investigator-initiated randomised, controlled, open-label clinical trial (The INITIATE Study)

Denmark, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 3, Randomized, Active-Controlled, Open-Label Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in Participants With HIV-1 Who Are Virologically Suppressed on Antiretroviral Therapy

Spain, Italy, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

The RIO Trial: A randomised placebo controlled trial of ART plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) vs ART plus placebo in treated Primary or Early stage HIV Infection on viral control off ART

Denmark, Germany, Spain, Netherlands, Sweden, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label dose-escalation study evaluating the safety, pharmacokinetics and antiviral activity of IMC-M113V in HLA-A*2:01 positive subjects with chronic HIV infection who are virologically suppressed.

Belgium, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Methotrexate as Remission Maintenance Therapy after Remission-Induction Therapy with Tocilizumab and Glucocorticoids in Subjects with Giant Cell Arteritis

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral Therapy Undergoing Analytical Treatment Interruption.

Germany, Denmark, Italy, France, Poland, Belgium +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Art trials by city

Art in Toronto Art in Vancouver Art in Montreal Art in Calgary Art in Edmonton Art in Ottawa Art in Winnipeg Art in Quebec City Art in Hamilton Art in Kitchener Art in London Art in Halifax Art in New York Art in Los Angeles Art in Chicago Art in Houston

Art clinical trials

Recruiting art studies right now

SCOPE Analytic Treatment Interruption Protocol

Art Therapy for Adults With Chronic Low Back Pain

A Prospective Study to Evaluate the Outcome of the Aurora Test Used With Blastocyst Transfer in an ICSI Cycle (Aurora-Blasto)

Reducing Stigma Through a Mental Health Art Exhibition and Its Printed Brochure

Reducing Systemic Inflammation in People on Antiretroviral Therapy

Healthy Effects of Adapted Aikido in People With Grip Disfunction

Comparing Acoustic Resonance Therapy (ART) vs. Cognitive Behavioral Therapy for Insomnia (CBT-I)

Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments

Antiretroviral Therapy for Acute and Chronic HIV Infection

Expressive Art Therapy for Elder Adults With Chronic Low Back Pain

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Stronger Families Through Art Therapy: A Mixed Methods Programme Evaluation Study

Also recruiting in Europe

Inhibiting the anti-apoptotic factor, BCL-2, at the time of ART initiation to promote apoptosis of HIV-infected cells and restrict the seeding of the HIV reservoir: An investigator-initiated randomised, controlled, open-label clinical trial (The INITIATE Study)

A Phase 3, Randomized, Active-Controlled, Open-Label Clinical Study to Evaluate a Switch to Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in Participants With HIV-1 Who Are Virologically Suppressed on Antiretroviral Therapy

The RIO Trial: A randomised placebo controlled trial of ART plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) vs ART plus placebo in treated Primary or Early stage HIV Infection on viral control off ART

An open-label dose-escalation study evaluating the safety, pharmacokinetics and antiviral activity of IMC-M113V in HLA-A*2:01 positive subjects with chronic HIV infection who are virologically suppressed.

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Methotrexate as Remission Maintenance Therapy after Remission-Induction Therapy with Tocilizumab and Glucocorticoids in Subjects with Giant Cell Arteritis

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral Therapy Undergoing Analytical Treatment Interruption.

Art trials by city

Other conditions